Ads
related to: subcutaneous injection sites landmarks for glucagon- Dosing Options
Two premeasured dosing options
No refrigeration required
- Free Demo Pen
Request a free demo pen
See Gvoke HypoPen® for yourself
- Access Patient Savings
Patients may pay as little as $25.
Help your patients save today.
- Gvoke HypoPen® Benefits
Discover Gvoke® benefits
Many benefits for patients
- Contact A Representative
Get in touch with a representative
Learn more about Gvoke HypoPen®
- Provider Resources
Explore resources to help patients
Gain insights and understanding
- Dosing Options
Search results
Results From The WOW.Com Content Network
Albiglutide (trade names Eperzan in Europe and Tanzeum in the US) is a glucagon-like peptide-1 agonist (GLP-1 agonist) drug marketed by GlaxoSmithKline (GSK) for treatment of type 2 diabetes. As of 2017 it is unclear if it affects a person's risk of death. [ 2 ]
The glucagon is given by intramuscular, intravenous or subcutaneous injection, and quickly raises blood glucose levels. To use the injectable form, it must be reconstituted prior to use, a step that requires a sterile diluent to be injected into a vial containing powdered glucagon, because the hormone is highly unstable when dissolved in solution.
Subcutaneous injection sites. Commonly used injection sites include: [3]: 723 The outer area of the upper arm. The abdomen, avoiding a 2-inch circle around the navel. The front of the thigh, between 4 inches from the top of the thigh and 4 inches above the knee. The upper back. The upper area of the buttock, just behind the hip bone.
2740 14652 Ensembl ENSG00000112164 ENSMUSG00000024027 UniProt P43220 O35659 RefSeq (mRNA) NM_002062 NM_021332 RefSeq (protein) NP_002053 NP_067307 Location (UCSC) Chr 6: 39.05 – 39.09 Mb Chr 17: 31.12 – 31.16 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse The glucagon-like peptide-1 receptor (GLP1R) is a G protein-coupled receptor (GPCR) found on beta cells of the pancreas and ...
Subcutaneous (under the skin). [22] This generally takes the form of subcutaneous injection, e.g. with insulin. Skin popping is a slang term that includes subcutaneous injection, and is usually used in association with recreational drugs. In addition to injection, it is also possible to slowly infuse fluids subcutaneously in the form of ...
Liraglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) also known as incretin mimetics. [6] It works by increasing insulin release from the pancreas and decreases excessive glucagon release. [6] Common side effects include low blood sugar, nausea, dizziness, abdominal pain, and pain at the site of injection.
Ad
related to: subcutaneous injection sites landmarks for glucagon